Clinical Research Directory
Browse clinical research sites, groups, and studies.
New AI-based Technologies in Nuclear Medicine
Sponsor: Azienda USL Reggio Emilia - IRCCS
Summary
The study aims to identify and predict radiopharmaceutical extravasation events using new semi-quantitative parameters and machine learning models. It involves dose rate measurements to develop metrics for real-time monitoring. It also investigates the correlation between extravasation and SUV correction in PET/CT diagnostics, providing an estimate of the correction factor necessary for accurate SUV evaluation in case of an extravasation event.
Official title: New AI-based Technologies for Even Safer and More Precise Nuclear Medicine
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
1500
Start Date
2021-07-30
Completion Date
2026-03-31
Last Updated
2025-09-15
Healthy Volunteers
No
Interventions
RadEye SPRD-ER device: spectrometric radiation detector capable of detecting gamma radiation.
Acquisition of data during the infusion of PET radiotracers and the administration of α and β emitting radiopharmaceuticals for therapy.
Locations (1)
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy